These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 10551706

  • 1. Causes of death in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial.
    J Am Coll Cardiol; 1999 Nov 01; 34(5):1552-9. PubMed ID: 10551706
    [Abstract] [Full Text] [Related]

  • 2. Renal disease and cardiac mortality in survivors of sudden cardiac death.
    Rathod A, Badheka A, Kizilbash M, Manickam P, Mohamad T, Bhat S, Afonso L, Jacob S.
    Acta Cardiol; 2010 Jun 01; 65(3):323-8. PubMed ID: 20666271
    [Abstract] [Full Text] [Related]

  • 3. Survival of antiarrhythmic or implantable cardioverter defibrillator treated patients with varying degrees of left ventricular dysfunction who survived malignant ventricular arrhythmias.
    Domanski MJ, Epstein A, Hallstrom A, Saksena S, Zipes DP.
    J Cardiovasc Electrophysiol; 2002 Jun 01; 13(6):580-3. PubMed ID: 12108501
    [Abstract] [Full Text] [Related]

  • 4. A history of heart failure predicts arrhythmia treatment efficacy: data from the Antiarrythmics versus Implantable Defibrillators (AVID) study.
    Brodsky MA, McAnulty J, Zipes DP, Baessler C, Hallstrom AP, AVID Investigators.
    Am Heart J; 2006 Oct 01; 152(4):724-30. PubMed ID: 16996848
    [Abstract] [Full Text] [Related]

  • 5. Relative effectiveness of the implantable cardioverter-defibrillator and antiarrhythmic drugs in patients with varying degrees of left ventricular dysfunction who have survived malignant ventricular arrhythmias. AVID Investigators. Antiarrhythmics Versus Implantable Defibrillators.
    Domanski MJ, Sakseena S, Epstein AE, Hallstrom AP, Brodsky MA, Kim S, Lancaster S, Schron E.
    J Am Coll Cardiol; 1999 Oct 01; 34(4):1090-5. PubMed ID: 10520795
    [Abstract] [Full Text] [Related]

  • 6. Antiarrhythmic drug use in the implantable defibrillator arm of the Antiarrhythmics Versus Implantable Defibrillators (AVID) Study.
    Steinberg JS, Martins J, Sadanandan S, Goldner B, Menchavez E, Domanski M, Russo A, Tullo N, Hallstrom A, AVID Investigators.
    Am Heart J; 2001 Sep 01; 142(3):520-9. PubMed ID: 11526368
    [Abstract] [Full Text] [Related]

  • 7. Mechanisms of death in the CABG Patch trial: a randomized trial of implantable cardiac defibrillator prophylaxis in patients at high risk of death after coronary artery bypass graft surgery.
    Bigger JT, Whang W, Rottman JN, Kleiger RE, Gottlieb CD, Namerow PB, Steinman RC, Estes NA.
    Circulation; 1999 Mar 23; 99(11):1416-21. PubMed ID: 10086963
    [Abstract] [Full Text] [Related]

  • 8. Comparison of arrhythmia recurrence in patients presenting with ventricular fibrillation versus ventricular tachycardia in the Antiarrhythmics Versus Implantable Defibrillators (AVID) trial.
    Raitt MH, Klein RC, Wyse DG, Wilkoff BL, Beckman K, Epstein AE, Coromilas J, Friedman PL, Martins J, Ledingham RB, Greene HL, Antiarrhythmics Versus Implantable Defibrillators Investigators.
    Am J Cardiol; 2003 Apr 01; 91(7):812-6. PubMed ID: 12667566
    [Abstract] [Full Text] [Related]

  • 9. Secondary prevention of sudden death: the Dutch Study, the Antiarrhythmics Versus Implantable Defibrillator Trial, the Cardiac Arrest Study Hamburg, and the Canadian Implantable Defibrillator Study.
    Cappato R.
    Am J Cardiol; 1999 Mar 11; 83(5B):68D-73D. PubMed ID: 10089843
    [Abstract] [Full Text] [Related]

  • 10. Do baseline characteristics accurately discriminate between patients likely versus unlikely to benefit from implantable defibrillator therapy? Evaluation of the Canadian implantable defibrillator study implantable cardioverter defibrillatory efficacy score in the antiarrhythmics versus implantable defibrillators trial.
    Exner DV, Sheldon RS, Pinski SL, Kron J, Hallstrom A.
    Am Heart J; 2001 Jan 11; 141(1):99-104. PubMed ID: 11136493
    [Abstract] [Full Text] [Related]

  • 11. Patients at lower risk of arrhythmia recurrence: a subgroup in whom implantable defibrillators may not offer benefit. Antiarrhythmics Versus Implantable Defibrillator (AVID) Trial Investigators.
    Hallstrom AP, McAnulty JH, Wilkoff BL, Follmann D, Raitt MH, Carlson MD, Gillis AM, Shih HT, Powell JL, Duff H, Halperin BD, Antiarrhythmics Versus Implantable Defibrillator (AVID) Trial Investigators.
    J Am Coll Cardiol; 2001 Mar 15; 37(4):1093-9. PubMed ID: 11263614
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Potential impact of antiarrhythmic drugs versus implantable defibrillators on the management of ventricular arrhythmias: the Midlands trial of empirical amiodarone versus electrophysiologically guided intervention and cardioverter implant registry data.
    Pathmanathan RK, Lau EW, Cooper J, Newton L, Skehan JD, Garratt CJ, Griffith MJ.
    Heart; 1998 Jul 15; 80(1):68-70. PubMed ID: 9764063
    [Abstract] [Full Text] [Related]

  • 14. Cost-effectiveness of the implantable cardioverter-defibrillator versus antiarrhythmic drugs in survivors of serious ventricular tachyarrhythmias: results of the Antiarrhythmics Versus Implantable Defibrillators (AVID) economic analysis substudy.
    Larsen G, Hallstrom A, McAnulty J, Pinski S, Olarte A, Sullivan S, Brodsky M, Powell J, Marchant C, Jennings C, Akiyama T, AVID Investigators.
    Circulation; 2002 Apr 30; 105(17):2049-57. PubMed ID: 11980684
    [Abstract] [Full Text] [Related]

  • 15. Design and results of the antiarrhythmics vs implantable defibrillators (AVID) registry. The AVID Investigators.
    Anderson JL, Hallstrom AP, Epstein AE, Pinski SL, Rosenberg Y, Nora MO, Chilson D, Cannom DS, Moore R.
    Circulation; 1999 Apr 06; 99(13):1692-9. PubMed ID: 10190878
    [Abstract] [Full Text] [Related]

  • 16. A comparison of the AVID and DAVID trials of implantable defibrillators.
    Sharma A, Epstein AE, Herre JM, Klein RC, Platia EV, Wilkoff B, Ledingham RB, Greene HL, Hallstrom AP, DAVID Investigators.
    Am J Cardiol; 2005 Jun 15; 95(12):1431-5. PubMed ID: 15950565
    [Abstract] [Full Text] [Related]

  • 17. [Antiarrhythmic therapy in patients with heart failure].
    Faber TS, Zehender M.
    Ther Umsch; 2000 May 15; 57(5):324-32. PubMed ID: 10859993
    [Abstract] [Full Text] [Related]

  • 18. Quality of life in the antiarrhythmics versus implantable defibrillators trial: impact of therapy and influence of adverse symptoms and defibrillator shocks.
    Schron EB, Exner DV, Yao Q, Jenkins LS, Steinberg JS, Cook JR, Kutalek SP, Friedman PL, Bubien RS, Page RL, Powell J.
    Circulation; 2002 Feb 05; 105(5):589-94. PubMed ID: 11827924
    [Abstract] [Full Text] [Related]

  • 19. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study.
    Connolly SJ, Hallstrom AP, Cappato R, Schron EB, Kuck KH, Zipes DP, Greene HL, Boczor S, Domanski M, Follmann D, Gent M, Roberts RS.
    Eur Heart J; 2000 Dec 05; 21(24):2071-8. PubMed ID: 11102258
    [Abstract] [Full Text] [Related]

  • 20. Comparison of clinical characteristics and frequency of implantable defibrillator use between randomized patients in the Antiarrhythmics Vs Implantable Defibrillators (AVID) trial and nonrandomized registry patients.
    Kim SG, Hallstrom A, Love JC, Rosenberg Y, Powell J, Roth J, Brodsky M, Moore R, Wilkoff B.
    Am J Cardiol; 1997 Aug 15; 80(4):454-7. PubMed ID: 9285657
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.